Additional file 5: of BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway

Table S3. The information about the tissue samples of the patients with type I endometrial cancer and the related clinic-pathological parameters. (DOCX 16 kb)